MONORAB Trademark

Trademark Overview

On Tuesday, January 3, 2017, a trademark application was filed for MONORAB with the United States Patent and Trademark Office. The USPTO has given the MONORAB trademark a serial number of 87287352. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, November 6, 2023. This trademark is owned by Nanjingjinsirui Science & Technology Biology Corp.. The MONORAB trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

Biochemicals, namely, monoclonal antibodies for in vitro scientific and research use, and for therapeutic and diagnostic use

Research and development in the biotechnology fields, namely, conducting custom monoclonal antibody production
monorab

General Information

Serial Number87287352
Word MarkMONORAB
Filing DateTuesday, January 3, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, November 6, 2023
Registration Number5325675
Registration DateTuesday, October 31, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2017

Trademark Statements

Goods and ServicesBiochemicals, namely, monoclonal antibodies for in vitro scientific and research use, and for therapeutic and diagnostic use
Goods and ServicesResearch and development in the biotechnology fields, namely, conducting custom monoclonal antibody production

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, January 11, 2017
Primary Code001
First Use Anywhere DateTuesday, February 14, 2017
First Use In Commerce DateTuesday, February 14, 2017
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 11, 2017
Primary Code042
First Use Anywhere DateWednesday, February 22, 2017
First Use In Commerce DateWednesday, February 22, 2017

Trademark Owner History

Party NameNANJING GENSCRIPT BIOTECH CO., LTD.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNANJING CITY, JIANGSU PROVINCE 211100
CN
Party NameNanjingjinsirui Science & Technology Biology Corp.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNanjing, Jiangsu 211100
CN
Party NameNanjingjinsirui Science & Technology Biology Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNanjing City 210014
CN
Party NameNanjingjinsirui Science & Technology Biology Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNanjing City 210014
CN

Trademark Events

Event DateEvent Description
Wednesday, January 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 6, 2017NEW APPLICATION ENTERED
Tuesday, March 28, 2017ASSIGNED TO EXAMINER
Tuesday, March 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 19, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 9, 2017PUBLISHED FOR OPPOSITION
Tuesday, May 9, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 31, 2017TEAS STATEMENT OF USE RECEIVED
Monday, July 31, 2017USE AMENDMENT FILED
Tuesday, August 22, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 25, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 19, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 20, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 22, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, September 28, 2017ELECTRONIC RECORD REVIEW COMPLETE
Friday, September 29, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 31, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, April 2, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 2, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, April 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 2, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Wednesday, March 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 15, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 31, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 9, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, November 6, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 6, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, November 6, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, May 30, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 30, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 30, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, May 30, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, May 30, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

monorab research monoclonal namely conducting fields antibody production biotechnology custom therapeutic